Clinical Trials Browser

Phase 3 × Unknown × Alemtuzumab × Clear all

NCT00725231 2012-05-07

A-CHOP-14

Phase 3 Unknown

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell